Updated July 23, 2026 4:59 pm ET
Listen
(3 min)
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1007 ET – Roche Holding is taking a disciplined approach to dealmaking since it doesn’t have its back against the wall to fill its drug pipeline, CEO Thomas Schinecker says on a call with **** ysts. The Swiss drugmaker is open to doing deals as long as they make sense from a financial perspective, Schinecker says. “We always make very detailed due diligence. We always have material-transfer agreements where we really test the molecules in our own hands…I’ve seen other companies lose a bit of discipline in this **** e,” he adds. Shares rise 4.4%. (adria.calatayudwsj.com)
#july
Listen
(3 min)
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1007 ET – Roche Holding is taking a disciplined approach to dealmaking since it doesn’t have its back against the wall to fill its drug pipeline, CEO Thomas Schinecker says on a call with **** ysts. The Swiss drugmaker is open to doing deals as long as they make sense from a financial perspective, Schinecker says. “We always make very detailed due diligence. We always have material-transfer agreements where we really test the molecules in our own hands…I’ve seen other companies lose a bit of discipline in this **** e,” he adds. Shares rise 4.4%. (adria.calatayudwsj.com)
#july
4 days ago
